About
Cell & Gene Therapies
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyStem Cell & Cellular TherapySeattle/Pacific Northwest
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
3
As Collaborator
2
Total Enrollment
12,089
By Phase
PHASE1: 3EARLY_PHASE1: 1
By Status
RECRUITING: 4ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
Today
Hover over trial bars to see details
Recent Trials
NCT06294236Lead Sponsor
Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)
PHASE1Recruiting
36 participants
Started: Apr 29, 2024 · Completed: Mar 31, 2028
NCT06285422Lead Sponsor
Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID)
PHASE1Recruiting
35 participants
Started: Apr 18, 2024 · Completed: Mar 31, 2029
NCT06239636Collaborator
First-in-human Safety Study of Hypoimmune Pancreatic Islet Transplantation in Adult Subjects With Type 1 Diabetes
EARLY_PHASE1Recruiting
2 participants
Started: Mar 8, 2024 · Completed: Jun 30, 2025
NCT05878184Lead Sponsor
Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)
PHASE1Active, not recruiting
16 participants
Started: May 2, 2023 · Completed: Nov 4, 2038
NCT03047369Collaborator
The Myelin Disorders Biorepository Project
N/ARecruiting
12,000 participants
Started: Dec 8, 2016 · Completed: Dec 8, 2030
Locations (1)
Headquarters
Seattle, WA, United States
Map
Loading map...